Stroke Diagnostics and Therapeutics Global Market Outlook - Trends, Forecast, and Opportunity Assessment (2014-2022)

The Global Stroke Diagnostics and Therapeutics Market is valued at $20.5 billion in 2014 and it is expected to reach nearly $34.4 billion by 2022, growing at a CAGR of 6.68% from 2014 to 2022. Stroke is referred to brain attack, this occurs when there is an interruption in the supply of blood to the brain which leads brain cells to die. The factors driving the Global Stroke Diagnostics and Therapeutics Market include technological advancement, growing aging population, and people suffering from diabetes, increasing health expenditure, hypertension and also increasing tobacco users. However factors such as unfavourable reimbursement scenario and high cost of treatments are restraining the market growth.

The Global Stroke Diagnostics and Therapeutics Market is categorized by type, application and geography. By type, the market is segmented into Diagnostics and Therapeutics. The Diagnostics is sub categorized into Magnetic Resonance Imaging (MRI), Computed Tomography Scan (CT scan), Electrocardiography, Carotid Ultrasound, Cerebral Angiography and Others. The Therapeutics is sub segmented into Tissue Plasminogen Activator, Antiplatelet, Antihypertensive and Anticoagulant. On the basis of application, the Stroke Diagnostics and Therapeutics Market is segmented into haemorrhagic stroke and ischemic stroke. Ischemic strokes are caused due to blocked or narrowed arteries that connect to the brain, which results in reduced blood flow in these arteries.

Hemorrhagic stroke is caused on account of the arteries in the brain either leaking blood or bursting open. In the TIAs, the flow of blood to the brain is only disrupted temporarily for a short period of time. By geography, it is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America has the largest market for stroke diagnostics and therapeutics followed by Europe. This is due to the increasing number of patients at the risk of developing stroke, technologically advanced equipment for the diagnosis and treatment of stroke, rise in research and development activities, increasing awareness among people about the causes of stroke, and improved healthcare infrastructure in the region.

The stroke diagnostics and therapeutics market in Asia is expected to witness the high growth rate in the next few years. This is due to growing aging population, evolving R&D activities for drug discovery and development, increasing government support in the form of funding, growing awareness about stroke and its causes, and developing healthcare infrastructure in the region. In addition, growing demographics and economies in the developing countries such as India, China, and Japan are expected to lead the growth in the stroke diagnostics and therapeutics market in Asia.

Some of the prominent players in Global Stroke Diagnostics and Therapeutics Market include Abbott Laboratories, Siemens AG, Stryker Corporation, GE Healthcare, Medtronic plc, Cordis Corporation, Genentech Inc., Boston Scientific Corporation, Coaxia Inc. and Philips Healthcare.

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Stroke Diagnostics and Therapeutics Market, By Type
5.1 Introduction
5.2 Diagnostics
5.2.1 Magnetic Resonance Imaging (MRI)
5.2.2 Computed Tomography Scan (CT scan)
5.2.3 Electrocardiography
5.2.4 Carotid Ultrasound
5.2.5 Cerebral Angiography
5.2.6 Others
5.3 Therapeutics
5.3.1 Tissue Plasminogen Activator
5.3.2 Antiplatelet
5.3.3 Antihypertensive
5.3.4 Anticoagulant

6 Global Stroke Diagnostics and Therapeutics Market, By Application
6.1
Introduction
6.2 Haemorrhagic Stroke
6.3 Ischemic Stroke

7 Global Stroke Diagnostics and Therapeutics Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia
7.4 Rest of the World
7.4.1 Latin America
7.4.2 Middle East
7.4.3 Africa
7.4.4 Others

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Abbott Laboratories
9.2 Siemens AG
9.3 Stryker Corporation
9.4 GE Healthcare
9.5 Medtronic plc
9.6 Cordis Corporation
9.7 Genentech Inc.
9.8 Boston Scientific Corporation
9.9 Coaxia Inc
9.10 Philips Healthcare

List of Tables
1 Global Stroke Diagnostics and Therapeutics Market Outlook, By Type (2014-2022) ($MN)
2 Global Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2014-2022) ($MN)
3 Global Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2014-2022) ($MN)
4 Global Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2014-2022) ($MN)
5 Global Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2014-2022) ($MN)
6 Global Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2014-2022) ($MN)
7 Global Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2014-2022) ($MN)
8 Global Stroke Diagnostics and Therapeutics Market Outlook, By Others (2014-2022) ($MN)
9 Global Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2014-2022) ($MN)
10 Global Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2014-2022) ($MN)
11 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2014-2022) ($MN)
12 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2014-2022) ($MN)
13 Global Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2014-2022) ($MN)
14 Global Stroke Diagnostics and Therapeutics Market Outlook, By Application (2014-2022) ($MN)
15 Global Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
16 Global Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2014-2022) ($MN)
17 North America Stroke Diagnostics and Therapeutics Market Outlook, By Type (2014-2022) ($MN)
18 North America Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2014-2022) ($MN)
19 North America Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2014-2022) ($MN)
20 North America Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2014-2022) ($MN)
21 North America Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2014-2022) ($MN)
22 North America Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2014-2022) ($MN)
23 North America Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2014-2022) ($MN)
24 North America Stroke Diagnostics and Therapeutics Market Outlook, By Others (2014-2022) ($MN)
25 North America Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2014-2022) ($MN)
26 North America Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2014-2022) ($MN)
27 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2014-2022) ($MN)
28 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2014-2022) ($MN)
29 North America Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2014-2022) ($MN)
30 North America Stroke Diagnostics and Therapeutics Market Outlook, By Application (2014-2022) ($MN)
31 North America Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
32 North America Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2014-2022) ($MN)
33 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Type (2014-2022) ($MN)
34 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2014-2022) ($MN)
35 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2014-2022) ($MN)
36 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2014-2022) ($MN)
37 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2014-2022) ($MN)
38 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2014-2022) ($MN)
39 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2014-2022) ($MN)
40 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Others (2014-2022) ($MN)
41 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2014-2022) ($MN)
42 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2014-2022) ($MN)
43 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2014-2022) ($MN)
44 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2014-2022) ($MN)
45 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2014-2022) ($MN)
46 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Application (2014-2022) ($MN)
47 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
48 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2014-2022) ($MN)
49 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Type (2014-2022) ($MN)
50 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2014-2022) ($MN)
51 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2014-2022) ($MN)
52 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2014-2022) ($MN)
53 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2014-2022) ($MN)
54 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2014-2022) ($MN)
55 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2014-2022) ($MN)
56 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Others (2014-2022) ($MN)
57 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2014-2022) ($MN)
58 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2014-2022) ($MN)
59 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2014-2022) ($MN)
60 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2014-2022) ($MN)
61 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2014-2022) ($MN)
62 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Application (2014-2022) ($MN)
63 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
64 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2014-2022) ($MN)
65 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Type (2014-2022) ($MN)
66 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2014-2022) ($MN)
67 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2014-2022) ($MN)
68 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2014-2022) ($MN)
69 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2014-2022) ($MN)
70 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2014-2022) ($MN)
71 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2014-2022) ($MN)
72 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Others (2014-2022) ($MN)
73 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2014-2022) ($MN)
74 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2014-2022) ($MN)
75 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2014-2022) ($MN)
76 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2014-2022) ($MN)
77 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2014-2022) ($MN)
78 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Application (2014-2022) ($MN)
79 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
80 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2014-2022) ($MN)